✉ info@chemsp.cn☎ +86-18553102138 ☎ 0531-84992235
📞 WhatsApp中文
Home › Product Catalog › Acalabrutinib

Acalabrutinib

CAS 1420477-60-6C26H23N7O2MW 465.5

Acalabrutinib (CAS 1420477-60-6) — formula C26H23N7O2, molecular weight 465.5; category pharmaceutical intermediates and APIs.

Product Description

Acalabrutinib (CAS 1420477-60-6) is a chemical raw material in the pharmaceutical intermediates and APIs category. Its molecular formula C26H23N7O2 comprises 26 C, 23 H, 7 N, 2 O atoms. Its molecular weight is about 465.5. Reported physicochemical data: LogP about 0.49. As a sourcing and distribution partner we help locate and compare this item across domestic and cross-border channels, arranging samples and batch orders with full COA and compliance files.

Product Overview

CAS Number1420477-60-6
Molecular FormulaC26H23N7O2
Molecular Weight465.5
LogP0.49
CategoryPharmaceutical Intermediates & APIs

Technical Profile

What this product is

Acalabrutinib is a pharmaceutical intermediate or API compound with CAS registry number 1420477-60-6 and molecular formula C26H23N7O2 (molecular weight 465.5), belonging to the pharmaceutical intermediates and APIs segment of chemical raw materials.

Identification

CAS number: 1420477-60-6

Its molecular formula C26H23N7O2 comprises 26 C, 23 H, 7 N, 2 O atoms.

Also known as: Acalabrutinib · 阿卡拉布替尼

Category: pharmaceutical intermediates and APIs

Frequently Asked Questions

What is the CAS number of Acalabrutinib?

The CAS registry number of Acalabrutinib is 1420477-60-6.

What is the molecular formula and molecular weight of Acalabrutinib?

Molecular formula C26H23N7O2, molecular weight 465.5.

What other names is Acalabrutinib known by?

It is also registered under: Acalabrutinib, 阿卡拉布替尼.

Which category does Acalabrutinib belong to?

Category: Pharmaceutical Intermediates & APIs.

Packaging & documentation

Packaging is agreed per order, from lab-scale packs to bulk, and confirmed with each order rather than fixed on the page. A Certificate of Analysis (COA) ships with every batch and MSDS is available; where the end use carries a regulatory limit (food contact, pharmaceutical or cosmetic), state the standard at enquiry and the grade is set against it.

PubChem Public Data

Independent reference data for Acalabrutinib (CAS 1420477-60-6), compiled from public chemistry databases.

Registry identifiers across databases

CAS Registry Number1420477-60-6
PubChem CID71226662
Molecular formulaC26H23N7O2
IUPAC name4-[8-amino-3-[(2S)-1-but-2-ynoylpyrrolidin-2-yl]imidazo[1,5-a]pyrazin-1-yl]-N-pyridin-2-ylbenzamide
UNII (FDA)I42748ELQW

Computed descriptors

Molecular Weight465.5
XLogP33
Hydrogen Bond Donor Count2
Hydrogen Bond Acceptor Count6
Rotatable Bond Count4
Exact Mass465.19132300
Monoisotopic Mass465.19132300
Topological Polar Surface Area119
Heavy Atom Count35

Physicochemical values on record

LogP0.49

Documented uses on record

    Acalabrutinib is indicated for: - The treatment of adult patients with Mantle Cell Lymphoma (MCL) who have received at least one prior therapy. - The treatment of adult patients with chronic lymphocytic leukemia and small lymphocytic lymphoma. - In combination with [rituximab] and [bendamustine] for the treatment of adult patients with previously untreated mantle cell lymphoma (MCL) who are ineligible for autologous hematopoietic stem cell transplantation (HSCT).Acalabrutinib is an oral inhibitor of Bruton’s tyrosine kinase that is used in the therapy of B cell malignancies including refractory mantle cell lymphoma and chronic lymphocytic leukemia. Acalabrutinib has been associated with mild-to-moderate serum enzyme elevations during therapy but has not been linked to instances of idiosyncratic acute liver injury, although it has been associated with cases of reactivation of hepatitis B which can be severe and even fatal.

    Synonyms and trade names

    Acalabrutinib; 1420477-60-6; ACP-196; acalabrutinibum; 4-[8-amino-3-[(2S)-1-but-2-ynoylpyrrolidin-2-yl]imidazo[1,5-a]pyrazin-1-yl]-N-pyridin-2-ylbenzamide; I42748ELQW; CHEBI:167707; DTXSID401026209; 4-[8-Amino-3-[(2S)-1-(1-oxo-2-butyn-1-yl)-2-pyrrolidinyl]imidazo[1,5-a]pyrazin-1-yl]-N-2-pyridinylbenzamide; 4-{8-amino-3-[(2S)-1-(but-2-ynoyl)pyrrolidin-2-yl]imidazo[1,5-a]pyrazin-1-yl}-N-(pyridin-2-yl)benzamide; 4-(8-Amino-3-((2S)-1-(1-oxo-2-butyn-1-yl)-2-pyrrolidinyl)imidazo(1,5-a)pyrazin-1-yl)-N-2-pyridinylbenzamide; 4-(8-amino-3-((2S)-1-(but-2-ynoyl)pyrrolidin-2-yl)imidazo(1,5-a)pyrazin-1-yl)-N-(pyridin-2-yl)benzamide; 4-(8-amino-3-((2S)-1-but-2-ynoylpyrrolidin-2-yl)imidazo(1,5-a)pyrazin-1-yl)-N-pyridin-2-ylbenzamide; RefChem:57414; L01XE51; DTXCID401510462

    Regulatory listings held on file

    GHS notification summary33.3% (1 / 3)

    GHS hazard classification

    GHS notification summary33.3% (1 / 3)
    Reported hazard statementsH373 (66.7%)

    This chemical does not meet GHS hazard criteria for 33.3% (1 of 3) of reports.

    H373 (66.7%): May causes damage to organs through prolonged or repeated exposure [Warning Specific target organ toxicity, repeated exposure]

    What the public record says

    Acalabrutinib · CAS 1420477-60-6 · C26H23N7O2. UNII I42748ELQW. LogP: 0.49.

    Source: PubChem / Wikidata; the batch COA governs where values differ.

Request a Quote

✉ info@chemsp.cn☎ +86-18553102138📞 WhatsAppEmail InquiryWhatsApp Inquiry

Supplier: Jinan Shenghe Chemical Co., Ltd.

中文页面: 阿卡拉布替尼

Shenghe Chemical|ChemSP
鲁ICP备19037000号-2